Brinker Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-5,051
| Closed | -$360K | – | 957 |
|
|
2019
Q2 | $360K | Sell |
5,051
-151
| -3% | -$10.8K | 0.01% | 769 |
|
|
2019
Q1 | $408K | Buy |
5,202
+1,068
| +26% | +$83.8K | 0.02% | 727 |
|
|
2018
Q4 | $350K | Buy |
4,134
+1,479
| +56% | +$125K | 0.02% | 702 |
|
|
2018
Q3 | $455K | Sell |
2,655
-187
| -7% | -$32K | 0.02% | 753 |
|
|
2018
Q2 | $367K | Buy |
2,842
+138
| +5% | +$17.8K | 0.01% | 806 |
|
|
2018
Q1 | $279K | Sell |
2,704
-56
| -2% | -$5.78K | 0.01% | 877 |
|
|
2017
Q4 | $236K | Sell |
2,760
-20
| -0.7% | -$1.71K | 0.01% | 915 |
|
|
2017
Q3 | $236K | Buy |
+2,780
| New | +$236K | 0.01% | 878 |
|
|
2017
Q2 | – | Sell |
-3,067
| Closed | -$202K | – | 780 |
|
|
2017
Q1 | $202K | Buy |
+3,067
| New | +$202K | 0.01% | 884 |
|